Blanket Purchase Agreement V797D60737-36C24223A0015
Award Date 6/1/23
Last Date to Order 5/31/25
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs to INO Therapeutics LLC, a foreign-owned, for-profit organization specializing in providing inhaled nitric oxide therapy systems and related medical gases to federal government healthcare agencies. The BPA, under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), has a ceiling value of $1,000,000 and a performance period through November 1, 2020. It is a single-award contract focused on delivering...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 to INO Therapeutics LLC, a foreign-owned for-profit organization. The contract has a ceiling value of $789,408.92 and a period of performance through September 30, 2027. The purpose of this BPA is to provide INOMAX nitric oxide gas cylinder delivery service to support respiratory treatments and healthcare programs for veterans, service members, and military...
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to INO Therapeutics LLC, a foreign-owned for-profit organization, for the provision of inhaled nitric oxide therapeutic gas. The contract, valued at $404,200, has a period of performance through March 2030. Under this BPA, INO Therapeutics will supply nitric oxide cylinders, gases, delivery machines, labor, and equipment to support respiratory treatments for the DHA. This includes providing inhaled nitric...
- This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to INO Therapeutics LLC, a foreign-owned for-profit company. The BPA, which was established under the Pharmaceuticals and Drugs GSA Schedule, is for the provision of inhaled nitric oxide therapy services to support respiratory treatments and related healthcare programs for veterans, service members, and military beneficiaries. INO Therapeutics has been...
- This Federal Supply Schedule contract has been awarded to INO Therapeutics LLC, a foreign-owned for-profit company, to provide inhaled nitric oxide therapy systems, medical gases, and related services to support respiratory treatments and healthcare programs for veterans, service members, and military beneficiaries. The contract, which has a total ceiling value of $36,000,000, was awarded by the Department of Veterans Affairs (VA) and is under the Pharmaceuticals and Drugs GSA Schedule...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 5 to RAS Enterprises LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB) and certified Historically Underutilized Business Zone (HUBZone) firm. The BPA, with a ceiling value of $0, is for the provision of medical gas cylinders, including liquid and compressed medical grade oxygen, nitrous oxide, nitrogen, and carbon dioxide, to VA medical...
- This Blanket Purchase Agreement (BPA) was awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Linde Gas & Equipment Inc., a foreign-owned, for-profit manufacturer and supplier of industrial and medical gases. The $250,000 multi-year BPA, with a period of performance through March 31, 2030, is for the procurement of bulk nitrogen. Linde Gas & Equipment Inc., doing business as Linde Gas & Equipment, is a leading global supplier of a wide range of...
- This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to United Therapeutics Corporation. The BPA utilizes the Pharmaceuticals and Drugs GSA Schedule to provide Orentiram, Remodulin, Tyvaso, and Unituxin for an estimated $60 million over a base year and four option years. The BPA aims to procure pharmaceutical products for treatment of pulmonary arterial hypertension and neuroblastoma. Orentiram, Remodulin, and Tyvaso are medications...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business. The single-award BPA, valued at up to $4.5 million, is for the delivery of the medication HYFTOR through June 2026. HYFTOR is likely used to treat conditions like post-traumatic stress disorder and chronic pain among veterans. In addition to this BPA, Nobelpharma America, LLC...
- The Department of Veterans Affairs Veterans Health Administration awarded a single-award blanket purchase agreement to Airgas USA LLC for the provision of various medical gases to the White River Junction Veterans Affairs Medical Center and associated community-based outpatient clinics in Vermont and New Hampshire. The agreement has a potential value of $275,000 and requires delivery of medical gases such as oxygen, nitrogen, nitrous oxide through September 2028 to support Veterans Health...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call 36C24223A0015-36C24224N0378 | INO Therapeutics LLC | $0 | 6/1/24 | 12/31/24 | 3/3/25 | |
BPA Call 36C24223A0015-36C24223N0550 | INO Therapeutics LLC | $172 | 6/28/23 | 5/31/24 | 6/9/25 | |
BPA Call 36C24223A0015-36C24225N0369 | INO Therapeutics LLC | $485 | 2/14/25 | 12/31/25 | 4/24/25 |